# Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication

> **NCT01678027** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **National Cancer Center, Korea** · enrollment: 1838 (actual)

## Conditions studied

- Gastric Cancer
- Helicobacter Pylori Infection
- Family Members

## Interventions

- **DRUG:** Placebo
- **DRUG:** LAC triple therapy

## Key facts

- **NCT ID:** NCT01678027
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2004-11
- **Primary completion:** 2018-12
- **Final completion:** 2035-12
- **Target enrollment:** 1838 (ACTUAL)
- **Last updated:** 2023-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01678027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01678027, "Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01678027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*